Related references
Note: Only part of the references are listed.The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy
Minyong Kang et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis
Hariruk Yodying et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
Narek Shaverdian et al.
CLINICAL LUNG CANCER (2016)
Comparison of Transthoracic Esophagectomy with Definitive Chemoradiotherapy as Initial Treatment for Patients with Esophageal Squamous Cell Carcinoma Who Could Tolerate Transthoracic Esophagectomy
Satoru Matsuda et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma
Sheng Han et al.
BMC CANCER (2015)
Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour
J. K. Pine et al.
BRITISH JOURNAL OF CANCER (2015)
Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival
M. Cummings et al.
BRITISH JOURNAL OF CANCER (2015)
Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model
Qiwen Deng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients
Wei-wei Zhang et al.
TUMOR BIOLOGY (2015)
Baseline neutrophil-lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use
D. Lorente et al.
ANNALS OF ONCOLOGY (2015)
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials
R. J. van Soest et al.
ANNALS OF ONCOLOGY (2015)
High Neutrophil-to-lymphocyte Ratio Persistent During First-line Chemotherapy Predicts Poor Clinical Outcome in Patients with Advanced Urothelial Cancer
Lorena Rossi et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy
Takeshi Terashima et al.
HEPATOLOGY RESEARCH (2015)
Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis
Xiao-Bin Gu et al.
SCIENTIFIC REPORTS (2015)
Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
J. Szkandera et al.
BRITISH JOURNAL OF CANCER (2014)
The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer
M. H. Kang et al.
BRITISH JOURNAL OF CANCER (2014)
Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer
In Rae Cho et al.
GASTRIC CANCER (2014)
Esophageal Carcinoma
Anil K. Rustgi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation
Lijun Shen et al.
RADIATION ONCOLOGY (2014)
A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours
Ashvin Paramanathan et al.
SURGICAL ONCOLOGY-OXFORD (2014)
The Combination of Platelet Count and Neutrophil Lymphocyte Ratio Is a Predictive Factor in Patients with Esophageal Squamous Cell Carcinoma
Ji-Feng Feng et al.
TRANSLATIONAL ONCOLOGY (2014)
The Modified Glasgow Prognostic Score Is an Independent Prognostic Factor in Patients with Inoperable Thoracic Esophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy
Peng Zhang et al.
JOURNAL OF CANCER (2014)
Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma
M. Santoni et al.
BRITISH JOURNAL OF CANCER (2013)
Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy
Yanwen Yao et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
Donald C. McMillan
CANCER TREATMENT REVIEWS (2013)
PITX2: A promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma
Jia-Xing Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival, and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma
Daniel Keizman et al.
EUROPEAN JOURNAL OF CANCER (2012)
Pretreatment Neutrophil-to-Lymphocyte Ratio in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram
Daniel Keizman et al.
ONCOLOGIST (2012)
Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of Postoperative Disease Recurrence in Esophageal Cancer
Reem Z. Sharaiha et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway
Rie Hamano et al.
CLINICAL CANCER RESEARCH (2011)
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer
Xin An et al.
BIOMARKERS (2010)
High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy
Steven C. H. Kao et al.
CLINICAL CANCER RESEARCH (2010)
High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
Li-Ru He et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Colorectal Liver Metastases Treated with Systemic Chemotherapy
Yoji Kishi et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases
K. J. Halazun et al.
EJSO (2008)
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer
SR Walsh et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus
M Stahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus
S Ishikura et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Share Paper
